Cardiovascular Research Center
Francesca Stillitano has not added Biography.
If you are Francesca Stillitano and would like to personalize this page please email our Author Liaison for assistance.
Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes.
Stem cells translational medicine Jan, 2014 | Pubmed ID: 24324277
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes.
Stem cell research & therapy Jan, 2014 | Pubmed ID: 24405778
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.
Nature communications , 2015 | Pubmed ID: 25923014
Genomic correction of familial cardiomyopathy in human engineered cardiac tissues.
European heart journal Nov, 2016 | Pubmed ID: 27450564
Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells.
Methods in molecular biology (Clifton, N.J.) , 2017 | Pubmed ID: 27910049
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.
eLife 01, 2017 | Pubmed ID: 28134617
Functional Human Beige Adipocytes From Induced Pluripotent Stem Cells.
Diabetes 06, 2017 | Pubmed ID: 28270520
Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility.
Circulation research 03, 2018 | Pubmed ID: 29449318
Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
Journal of molecular and cellular cardiology Jun, 2018 | Pubmed ID: 29752948
Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies.
Methods in molecular biology (Clifton, N.J.) , 2018 | Pubmed ID: 29987817
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues.
Stem cell research & therapy Dec, 2019 | Pubmed ID: 31801634
Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias.
Journal of personalized medicine Jun, 2021 | Pubmed ID: 34204946
Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members.
Stem cell research Apr, 2022 | Pubmed ID: 35247838
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts.
Metabolism: clinical and experimental Jan, 2023 | Pubmed ID: 36375644
Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy.
International journal of molecular sciences Jan, 2023 | Pubmed ID: 36768995
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유